419 related articles for article (PubMed ID: 25512232)
21. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human.
Andersson TB; Kanebratt KP; Kenna JG
Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):909-20. PubMed ID: 22568886
[TBL] [Abstract][Full Text] [Related]
22. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins.
Gerets HH; Tilmant K; Gerin B; Chanteux H; Depelchin BO; Dhalluin S; Atienzar FA
Cell Biol Toxicol; 2012 Apr; 28(2):69-87. PubMed ID: 22258563
[TBL] [Abstract][Full Text] [Related]
23. HepG2 (C3A) spheroids show higher sensitivity compared to HepaRG spheroids for drug-induced liver injury (DILI).
Basharat A; Rollison HE; Williams DP; Ivanov DP
Toxicol Appl Pharmacol; 2020 Dec; 408():115279. PubMed ID: 33068618
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail.
Berger B; Donzelli M; Maseneni S; Boess F; Roth A; Krähenbühl S; Haschke M
Front Pharmacol; 2016; 7():443. PubMed ID: 27917125
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of 3D culture methods on human HepG2 cells.
Luckert C; Schulz C; Lehmann N; Thomas M; Hofmann U; Hammad S; Hengstler JG; Braeuning A; Lampen A; Hessel S
Arch Toxicol; 2017 Jan; 91(1):393-406. PubMed ID: 26872951
[TBL] [Abstract][Full Text] [Related]
26. Galactosylated cellulosic sponge for multi-well drug safety testing.
Nugraha B; Hong X; Mo X; Tan L; Zhang W; Chan PM; Kang CH; Wang Y; Beng LT; Sun W; Choudhury D; Robens JM; McMillian M; Silva J; Dallas S; Tan CH; Yue Z; Yu H
Biomaterials; 2011 Oct; 32(29):6982-94. PubMed ID: 21741702
[TBL] [Abstract][Full Text] [Related]
27. Three-dimensional HepaRG spheroids as a liver model to study human genotoxicity in vitro with the single cell gel electrophoresis assay.
Mandon M; Huet S; Dubreil E; Fessard V; Le Hégarat L
Sci Rep; 2019 Jul; 9(1):10548. PubMed ID: 31332230
[TBL] [Abstract][Full Text] [Related]
28. Three-dimensional HepaRG model as an attractive tool for toxicity testing.
Leite SB; Wilk-Zasadna I; Zaldivar JM; Airola E; Reis-Fernandes MA; Mennecozzi M; Guguen-Guillouzo C; Chesne C; Guillou C; Alves PM; Coecke S
Toxicol Sci; 2012 Nov; 130(1):106-16. PubMed ID: 22843569
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a Three-Dimensional Primary Human Hepatocyte Spheroid Model: Adoption and Industrialization for the Enhanced Detection of Drug-Induced Liver Injury.
Schofield CA; Walker TM; Taylor MA; Patel M; Vlachou DF; Macina JM; Vidgeon-Hart MP; Williams A; McGill PJ; Newman CF; Sakatis MZ
Chem Res Toxicol; 2021 Dec; 34(12):2485-2499. PubMed ID: 34797640
[TBL] [Abstract][Full Text] [Related]
30. Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing.
Tostões RM; Leite SB; Serra M; Jensen J; Björquist P; Carrondo MJ; Brito C; Alves PM
Hepatology; 2012 Apr; 55(4):1227-36. PubMed ID: 22031499
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of an in vitro three-dimensional HepaRG spheroid model for genotoxicity testing using the high-throughput CometChip platform.
Seo JE; He X; Muskhelishvili L; Malhi P; Mei N; Manjanatha M; Bryant M; Zhou T; Robison T; Guo X
ALTEX; 2022; 39(4):583-604. PubMed ID: 35791290
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies.
Kanebratt KP; Andersson TB
Drug Metab Dispos; 2008 Jul; 36(7):1444-52. PubMed ID: 18385292
[TBL] [Abstract][Full Text] [Related]
33. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.
Aninat C; Piton A; Glaise D; Le Charpentier T; Langouët S; Morel F; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2006 Jan; 34(1):75-83. PubMed ID: 16204462
[TBL] [Abstract][Full Text] [Related]
34. 3D engineered In vitro hepatospheroids for studying drug toxicity and metabolism.
Chitrangi S; Nair P; Khanna A
Toxicol In Vitro; 2017 Feb; 38():8-18. PubMed ID: 27794450
[TBL] [Abstract][Full Text] [Related]
35. Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.
Nelson LJ; Morgan K; Treskes P; Samuel K; Henderson CJ; LeBled C; Homer N; Grant MH; Hayes PC; Plevris JN
Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):30-37. PubMed ID: 27285124
[TBL] [Abstract][Full Text] [Related]
36. 3D spheroid cultures improve the metabolic gene expression profiles of HepaRG cells.
Takahashi Y; Hori Y; Yamamoto T; Urashima T; Ohara Y; Tanaka H
Biosci Rep; 2015 May; 35(3):. PubMed ID: 26182370
[TBL] [Abstract][Full Text] [Related]
37. Preliminary Evaluation of Three-Dimensional Primary Human Hepatocyte Culture System for Assay of Drug-Metabolizing Enzyme-Inducing Potential.
Arakawa H; Kamioka H; Jomura T; Koyama S; Idota Y; Yano K; Kojima H; Ogihara T
Biol Pharm Bull; 2017; 40(7):967-974. PubMed ID: 28674261
[TBL] [Abstract][Full Text] [Related]
38. Organotypic 3D HepaRG Liver Model for Assessment of Drug-Induced Cholestasis.
Ramaiahgari SC; Ferguson SS
Methods Mol Biol; 2019; 1981():313-323. PubMed ID: 31016663
[TBL] [Abstract][Full Text] [Related]
39. CYP1A1 and CYP1A2 expression levels are differentially regulated in three-dimensional spheroids of liver cancer cells compared to two-dimensional monolayer cultures.
Terashima J; Goto S; Hattori H; Hoshi S; Ushirokawa M; Kudo K; Habano W; Ozawa S
Drug Metab Pharmacokinet; 2015 Dec; 30(6):434-40. PubMed ID: 26643992
[TBL] [Abstract][Full Text] [Related]
40. Generation of proliferating human hepatocytes using Upcyte® technology: characterisation and applications in induction and cytotoxicity assays.
Burkard A; Dähn C; Heinz S; Zutavern A; Sonntag-Buck V; Maltman D; Przyborski S; Hewitt NJ; Braspenning J
Xenobiotica; 2012 Oct; 42(10):939-56. PubMed ID: 22524704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
